All posts by imreal

Society: Disabled Issues / Disabilities

National Museum of the Surface Navy Names Fiona Ma Recipient of 2023 Freedom of the Seas Humanitarian Service Award

Leave a comment


As the primary banker for the State of California, Treasurer Ma’s office acted quickly to provide resources to small businesses and expand access to healthcare facilities during the COVID-19 pandemic. In addition to growing and revamping California’s affordable housing and homeless housing programs, Treasurer Ma has funded clean energy projects, which resulted in the creation of new jobs, and dramatically increased the ability of Californians to save for college and retirement, live with a disability, and achieve a better quality of life.

“Throughout her career, Fiona Ma has proven her dedication to protecting and improving the lives of the citizens of California, and in her current role as State Treasurer, she has been instrumental in helping individuals and businesses navigate through, survive, and recover from an extraordinarily challenging time in our state’s history,” stated retired Navy Rear Admiral Mike Shatynski, Chairman of the Board of the National Museum of the Surface Navy. “We are honored to be able to present Treasurer Ma with this award in recognition of her invaluable contributions and efforts to provide relief and assistance to the citizens of the state of California.”

The annual Freedom of the Seas Awards event is held in honor of the Battle of Leyte Gulf, considered to be the largest naval battle of World War II. Attendance at the award event, which is by invitation only, includes top leaders from the education, veteran, community, industry, government, and military sectors. For information on sponsorship opportunities, contact Kyle Aube, Director of Development at [email protected].

About the Freedom of the Seas Awards

The Freedom of the Seas Awards is the premiere annual event of the National Museum of the Surface Navy at the Battleship IOWA. The event is held in honor of the anniversary of the Battle of Leyte Gulf, the largest naval battle in the history of the world, which occurred during World War II. The Awards honors those that embody the core principles of the American Surface Navy’s mission to protect and defend our oceans for the benefit of the free world.

About the National Museum of the Surface Navy

Scheduled to open in 2025 aboard the historic Battleship USS IOWA Museum, the National Museum of the Surface Navy is the museum for America’s Surface Navy. The museum’s mission is to raise America’s awareness of the importance of the United States Surface Naval Forces’ role in international relations, free trade, humanitarian assistance, and technological innovation, not just in the past but today and into the future.

Located in the Port of Los Angeles in San Pedro, Calif., Battleship USS IOWA Museum is one of the top five museums and attractions in Los Angeles, bringing the ship’s history to life through in-person and virtual tours and educational programs for youth. In addition to providing a natural platform for veterans and patriotic civilians to come together as a community, Battleship USS IOWA Museum provides a wide array of impactful programs and resources that support the critical needs of our military and veterans.

Media Contact

Ken Hagihara, Battleship USS Iowa, 1 9497684423 101, [email protected], https://pacificbattleship.com/

SOURCE Battleship USS Iowa

Health

The DRIPBaR Launched in Trophy Club, TX on August 30th!

Leave a comment


Kickstart Your Wellness Routine With IV Therapy

Clients will have a variety of IV Lifestyle and IV Health Support Drips to choose from. All of these services are designed to help customers look and feel their very best, whether they are looking for a quick boost or a more long-term wellness solution. For those who don’t have time for a full vitamin infusion but want the benefit, clients can choose one of six IM Quick Shots that are designed to give the body a boost.

The DRIPBaR Trophy Club is thrilled to serve the local community, as well as the surrounding areas of Roanoke, Westlake, Southlake, Argyle, Northlake, Justin, and Keller, TX.

To celebrate their arrival, The DRIPBaR Trophy Club is offering 50% off as well as a FREE B12 Shot when an appointment is booked before opening day, August 30th.

About The DRIPBaR

Established in 2016, The DRIPBaR is a nationwide franchise dedicated to enhancing individuals’ physical and mental well-being through intravenous therapies. Leveraging breakthroughs in cellular and biological science, The DRIPBaR empowers clients to combat chronic illness, address aging effects, and attain optimal balance in their wellness journey.

By prioritizing dynamic treatments and medical advancements, the franchise aims to bridge the divide between personalized care and treatment-focused medicine. Presently, The DRIPBaR boasts over 600 upcoming locations in different stages of development across 28 states, with over 70 locations already in operation. For more information, visit their website.

The DRIPBR Trophy Club

625 Parkview Dr #103B

Trophy Club, TX 76262

(817) 753-3055

[email protected]

Media Contact

Jamie Deevers, The DRIPBaR Trophy Club, 1 (817) 753-3055, [email protected], https://www.thedripbar.com/trophy-club/

SOURCE The DRIPBaR Trophy Club

Health

The MOG Project, Pediatric Neurologist Secure CDC Approval to Adopt ICD-10 Code for Rare Disease MOGAD

Leave a comment


CDC code will guide better treatments, cut insurance delays related to rare neuroinflammatory condition.

OLNEY, Md., Oct. 2, 2023 /PRNewswire-PRWeb/ — The MOG Project, a nonprofit organization committed to supporting the research and treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) announced that its Executive Director Julia Lefelar, with support from The MOG Project Executive Board and Children’s Hospital Los Angeles (CHLA) Pediatric Neurologist Jonathan Santoro, MD, secured approval to have the US Centers for Disease Control and Prevention (CDC) create an ICD-10 code for MOGAD. As of October 1, 2023, an official code for MOGAD is included in the 10th edition of the International Classification of Diseases (ICD) and Related Health Problems, which is relied upon by physicians and insurance providers to classify diagnoses and advise treatment.

Without a CDC code, MOGAD patients had previously been grouped in with patients with similar diseases like neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, transverse myelitis and even multiple sclerosis. This complicated the process of getting an accurate diagnosis of MOGAD for patients and led to insurance delays and in some cases inappropriate treatments. The classification system was created by the World Health Organization but is coordinated in the U.S. under the CDC.

“MOGAD patients like me need an ICD-10 code for everything from properly recording a diagnosis, to securing health insurance coverage, to encouraging clinical trials and obtaining FDA-approved medications indicated for MOGAD,” said Lefelar. “For the MOGAD community, this CDC code is more than a win for better health outcomes and fewer insurance delays, it gives our rare disease an identity and legitimizes it.”
MOGAD is a neuroinflammatory condition in which the immune system attacks vital myelin oligodendrocyte glycoproteins in the optic nerve, brain and/or spinal column. This rare disease is still widely unknown as an antibody test to diagnose it was not widely available until 2017.

To obtain the CDC’s approval, Lefelar and Santoro, director of the Neuroimmunology and Demyelinating Disorders Program and director of Research at the Neurologic Institute at CHLA, researched the process, submitted a proposal making the case for the ICD-10 code in the fall of 2021 and then worked to rally support from the neurologist and MOGAD community. After an initial rejection, Lefelar and Santoro were invited to give an advocacy appeal and speak about the medical need for the code in the fall of 2022. The CDC passed a final rule calling for the new code in March 2023, which officially became effective October 1. On September 15, Lefelar spoke to leaders in brain health at the Brain Health & Research Day of the 78th United Nations General Assembly encouraging the WHO to adopt a similar proposal for their ICD-11 coding platform, submitted by The MOG Project in 2020, for MOGAD patients around the world.

“The addition of a MOGAD specific ICD-10 code allows patients to better access the therapies that they need to treat their disease,” said Santoro. “Further, it allows for disease monitoring across the country, which will increase knowledge and research on this rare neuroimmunology disorder.”

About The MOG Project: The MOG Project is a 501(c)3 nonprofit committed to raising awareness and supporting the treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease, or MOGAD. Founded in 2017, The MOG Project is supported by a medical advisory board made up of leaders from top U.S. neuroimmunology labs. For more information about The MOG Project, visit https://mogproject.org/.

Media Contact

Eileen Coyne, Kimball Hughes Public Relations, 610-559-7585 x 107, [email protected]

SOURCE The MOG Project

Health

Shea Physical Therapy is Thrilled to Announce the Opening of a New Clinic in Corpus Christi

Leave a comment


Shea PT specializes in providing exceptional physical therapy through a combination of evidence-based practice, care excellence, and clinical excellence. Services offered from the Corpus Christi East (Texan Trail) clinic will include orthopedic physical therapy, vestibular treatment, injury prevention, chronic pain management and treatment, sports medicine, workplace injuries and more.

“I am excited to be opening this new location in Corpus Christi and to be a part of the Shea PT team,” says Houck. “This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Corpus Christi community. I look forward to helping the community work to achieve their optimal level of function.”

For more information about the new Corpus Christi East (Texan Trail) clinic and a full list of Shea PT’s services and offerings, please visit sheaphysicaltherapy.com. To book an appointment with Thomas, please call 361-260-6420.

About Shea Physical Therapy: Shea Physical Therapy (Shea PT) is a Texas-based, private physical therapy practice group. As a proud member of the Confluent Health family, Shea PT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit sheaphysicaltherapy.com.

Media Contact

Betsy Appleton, Confluent Health, 502-536-4584, [email protected], www.goconfluent.com

SOURCE Confluent Health

Health

Mind-Body Medicine Clinically Proven to Help Treat Anxiety and Depression in Cancer Survivors

Leave a comment


These experts encourage the use of mindfulness techniques and other integrative therapies to help adults dealing with cancer manage their feelings of anxiety and depression. Their detailed set of guidelines, which can be found in the Journal of Clinical Oncology, carefully describe how well techniques like yoga, relaxation exercises, hypnosis, acupuncture, and music therapy, work in reducing anxiety and depression during cancer treatment.

“Depression and anxiety often emerge when patients complete their treatment and begin to reflect on the trauma they’ve endured,” said Dr. Ashwin Mehta. “Recognizing that not all patients prefer traditional medication for these symptoms, we’ve achieved remarkable success with mindfulness-based interventions and other integrative therapies in helping patients overcome these challenges.”

The guideline firmly champions mindfulness-based interventions (MBIs), encompassing mindfulness-based stress reduction, meditation, and mindful movement. These integrative interventions are thoughtfully recommended for patients in both active treatment and the post-treatment phase, owing to their well-documented benefits. Integrative medicine is a wellness model that applies the latest science in holistic approaches to optimize health. Memorial’s team of experts is experienced in providing both preventive health plans and supportive care to patients who are being treated for various chronic illnesses, including cancer.

“Integrative medicine has played a pivotal role in the health and healing journey at Memorial Cancer Institute, offering support throughout and beyond treatment,” asserts Dr. Mehta. “The availability of the SIO-ASCO guideline to clinicians and individuals battling cancer is truly life-changing. As depression and anxiety often set in after cancer treatment concludes, we want patients to know that we are here to provide unwavering support.”

Memorial Cancer Institute, unwavering in its commitment to prioritize patient care and enhance healthcare services, is on the verge of completing a state-of-the-art $125 million facility. This visionary expansion will include a dedicated integrative medicine office suite and a serene sanctuary designed for yoga and meditation. The new location is slated to open its doors in November 2023.

Dr. Mehta, who assumed the role of Medical Director of Integrative Medicine at Memorial Healthcare System in October 2015, brings his expertise in nutrition, exercise, sleep, yoga, and mindfulness to the forefront. The integrative team, comprised of specialists in complementary techniques, continuously develops innovative, patient-centered wellness programs aimed at improving the quality of life throughout the patient’s care journey. The Integrative Medicine Division conducts “Next Step Orientation Sessions,” introducing new Memorial Cancer Institute patients to the array of supportive care services available, including the Integrative Cancer Survivorship program, empowering patients with holistic and evidence-based techniques to maintain a cancer-free life post-treatment.

For a deeper insight into Memorial Cancer Institute’s approach to integrative medicine, please visit https://www.mhs.net/services/integrative-medicine.

###

About The Society for Integrative Oncology
Founded in 2003, SIO is the premier multi-disciplinary international professional organization for integrative oncology. The mission of the SIO is to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer. SIO enables communication, education, and research to occur by bringing together practitioners and researchers across professions focused on the care of cancer patients and survivors. Members share the common goals of excellent comprehensive patient care, enhancement of anti-cancer therapy, supportive care, and prevention of cancer. SIO members are part of a unique multidisciplinary community of oncologists, nurses, psychologists, social workers, nutritionists, complementary therapy practitioners, naturopathic doctors, acupuncturists, massage therapists, epidemiologists, researchers, and many other health care practitioners. Learn more at https://integrativeonc.org/.

About Memorial Healthcare System
South Florida-based Memorial Healthcare System is a national leader in quality care and patient, physician, and employee satisfaction. Its commitment to deeper caring, smarter health, and community outreach prioritizes a person-centered approach that has delivered safe, positive outcomes for more than 70 years.

Featuring multi-disciplinary collaboration, research, innovation, and transparency, Memorial is focused on removing barriers, increasing access, and providing equitable care throughout its region. It employs a staff of more than 15,000 and operates six hospitals, numerous primary, urgent, and 24/7 care facilities, a health specialty center, and nursing home. To learn more, visit mhs.net and connect on Facebook, X (formerly Twitter), Instagram, and LinkedIn.

Media Contact

Yanet Obarrio Sanchez, Memorial Healthcare System, 954-265-1136, [email protected], mhs.net

SOURCE Memorial Healthcare System



Health

Xtalks Announces its Life Science Webinar Calendar for October 2023

Leave a comment


Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, fundamental research, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain, pharmaceutical regulation and preclinical.

TORONTO, Oct. 2, 2023 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

BIOMARKERS
October 3– Precision Medicine and Alzheimer’s Disease: Overcoming Biomarker Testing Barriers for Alzheimer’s Disease Patients

CELL AND GENE THERAPY
October 5– Updates in Cell and Gene Therapy: Current Trends and Operational Considerations
October 16– Cell and Gene Therapy Clinical Trials’ Regulatory Strategies and Safety Considerations

CLINICAL TRIALS
October 3– Clinical Sample Management: Expecting the Unexpected – How to Avoid Losing a Sample
October 4– Harnessing AI for Clinical Trial Workflow Management
October 6– Patient-Centric Clinical Trials: Strategies for Accelerated Enrollment, Data Insights and Trial Success
October 10– Understanding the Power of Patients: Examples of Patient Impact on Clinical Development
October 12– Advances in oncological imaging: Tumour growth rate modelling and radiomics
October 12– Keeping up with ClinOps: Why and how to expedite delivery
October 13– Incorporating the Patient’s Voice in NASH Clinical Trials
October 18– Improve Data Reliability from MADRS and HAM-D Assessments in Clinical Trials: Scientific and Operational Recommendations
October 19– How AI is changing cancer research, the site perspective
October 26– A Step-by-Step Approach to eSource in Clinical Trials
October 27– Clinical Trial Risk Identification, Management and Reporting from Clinical Development to Marketing
October 30– The Evolution of GLP-1s in Patient-Centric Clinical Development

COMMERCIALIZATION & HEOR
October 31– Fast, Faster, Fastest: Is It Time for Automated Model Building?

DRUG DISCOVERY & DEVELOPMENT
October 10– Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products
October 11– Model Informed Drug Development: Application to Project Optimus
October 16– EEG Analysis and Animal Behavior in CNS Drug Development
October 17– Covalent Drug Discovery: Basic Principles and Analysis of Current Patent Literature
October 18– Magic Rings — How to Solve Your Parenteral Formulation Challenges with Cyclodextrins
October 24– Drug Labeling Studies in Clinical Pharmacology: Recent FDA/EMA Updates
October 31– AI: Challenges, Opportunities and Impact for Drug Discovery Teams

FUNDAMENTAL RESEARCH
October 3– Optimizing Sleep During Perimenopause and Beyond
October 6– Adaptive Immune Response in Narcolepsy Type 1
October 25– Underneath the Lost Kilos: Weight Loss in Metabolic Disease

HEALTHCARE
October 20– Beyond the Token: Why Your Healthcare Data and Integration Strategy Matters
October 23– How to Co-Design Your Solution with Patients

LABORATORY TECHNOLOGY
October 2- 4th Generation Lentiviral Vectors: An Improved Gene Delivery System
October 5– An Automated Peptide Synthesis and Purification Platform to Overcome Operational Complexity
October 6– Experiences with a Rapid Multiplex NAT System for Bloodstream Infections at a Tertiary Cancer Center
October 11– Exploring the Benefits of Parallel Multiplex Immunohistochemistry
October 13– dPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development
October 16– Cell-Free Riboswitches: Engineering and Applications
October 23– Mass-directed Fraction Collection in High Performance Liquid Chromatography
October 24– Managing Critical Lab Materials through Connected Digital Solutions
October 25– DNase-I Application for dPCR Treatments in AAV Workflows
October 27– Assay Platforms for PROTAC in Drug Discovery and Beyond
October 31– Somatic Mutations in Single-Cell Sequencing: Separating Signal from Noise

MEDICAL DEVICE
October 5– Are Sensors and Wearables Really the Future of Data Capture in Clinical Trials?

PATIENT RECRUITMENT & RETENTION
October 10– Taking a proactive and holistic approach to diversity assessment and planning
October 12– AI in Clinical Research: How to Maximize Efficiency and Patient Centricity
October 18– The Power of Community Engagement in Clinical Research

PHARMA MANUFACTURING & SUPPLY CHAIN
October 11– Upstream Process Development for Better Yield and Product Quality
October 19– 2023 RAPS Article of The Year: Addressing the Risks of Nitrosamine Contamination in Pharmaceuticals
October 30– USP 922: The Impact of Water Activity Testing on the Quality and Stability of Tablets and Capsules

PHARMACEUTICAL REGULATION
October 20– Navigating the Future: The Evolution of REMS and the Path Ahead

PRECLINICAL
October 4– AI and Machine Learning with Advanced Preclinical Cancer Models for Improved Clinical Translation
October 30– AI in Biomedical Research: Regulatory & Technology Perspectives

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com.

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected], www.xtalks.com

SOURCE Xtalks

Health

Challenges and Strategies for High-Potent and Low-Dosed Products, Upcoming Webinar Hosted by Xtalks

Leave a comment


Implementing specific concepts for shared facilities and establishing highly flexible setups become crucial factors for the fast and efficient development of drug products. These tailored approaches allow for quicker adaptation to the unique requirements of each HPAPI, ensuring safety, and maintaining high productivity levels.

Drug developers must be proactive in their approach to adapt to the current challenges in the R&D pipeline. By effectively handling HPAPIs, devising targeted therapy solutions and employing advanced formulation technologies, they can pave the way for successful drug development in the future.

Join this webinar to get insights into the challenges and strategies in drug product development and manufacturing and the safe and flexible handling of HPAPIs.

Join experts from Aenova Group, Florent Bordet, Chief Scientific Officer (CSO); Klaus Pollinger, PhD, Head of Manufacturing Science & Technology; and Martina Breuer, PhD, Head of Operations / QP, for the live webinar on Tuesday, October 10, 2023, at 11am EDT (4pm GMT/UK).

For more information, or to register for this event, visit Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products.

ABOUT AENOVA GROUP

The Aenova Group is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. As a one-stop store, Aenova develops, produces and packages all common dosage forms, product groups and active ingredient classes from pharmaceuticals to dietary supplements for human and animal health: solid, semi-solid and liquid, sterile and non-sterile, high and low dose, OEB 1 to 5 (Occupational Exposure Band). Approximately 4,000 employees at 14 sites in Europe and the U.S. contribute to the company’s success. For more information, visit http://www.aenova-group.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health

Upstream Process Development for Better Yield and Product Quality, Upcoming Webinar Hosted by Xtalks

Leave a comment


Ambr® 250 high-throughput 24-way bioreactor system integrated with the MODDE DOE software and bioanalyzers can be used at different stages of upstream development and upstream process optimization. Upstream process development, especially testing media, screening feeding strategy and characterizing operating conditions is performed using the resource-efficient tool.

The application of bioreactor vessels with similar geometry and aspect ratio is encouraged to simplify the scaling process between bioreactors. The identification of potential critical process parameters using multi-parallel bioreactors is followed by the definition of acceptable operation ranges. The qualifying mini-scale systems are also used as the scale-down model to mimic the process at larger scales and determine the design space based on the rich statistically relevant data. The generation of reproducible and scalable data shortens the tech transfer timeline for accelerated delivery of products to patients.

Join this webinar where Dr. Ali Abghari will discuss the importance of upstream process development in elevating titer and quality, as well as achieving a robust, scalable process.

Join Ali Abghari, PhD, Senior Scientist, Aragen, for the live webinar on Wednesday, October 11, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Upstream Process Development for Better Yield and Product Quality.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected] 

SOURCE Xtalks

Health

Exploring the Benefits of Parallel Multiplex Immunohistochemistry, Upcoming Webinar Hosted by Xtalks

Leave a comment


Combining chromogenic or fluorescent UltraPlex in your research with image analysis software yields large amounts of data produced in less time versus other multiplex techniques.

Join this webinar to gain insights into UltraPlex multiplex immunohistochemistry and the importance of a modular approach in designing multiplex assays.

Join Matt Levin, BSc, R&D Manager, Leica Biosystems, for the live webinar on Wednesday, October 11, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Exploring the Benefits of Parallel Multiplex Immunohistochemistry.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks